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response of sympathetic and hemodynamic parameters during exercice (all
p<0,05) but response after PE-CA was blunted.
Conclusion: In patients with chronic heart failure, hyperoxia did not
altered mecanoreflex MSNA activation. In contrast, hyperoxia attenuates
metaboreflex activation. This effect could lead to a diminished activation of
the sympathetic nervous tone in heart failure and have beneficial effects.
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Background: Few data are available about real life and management of
patients heart failure with preserved systolic function (HF-PSF).
Objective: To describe patients, disease characteristics and treatment strat-
egies implemented in HF-PSF patients hospitalized for confirmed acute HF
with LVEF≥45%.
Methods: An observational study was conducted in 68 hospital in
France with 2 steps: (1) a registry part in patients hospitalized for confirmed
acute HF for estimation of proportion of HF-PSF patients in the overall HF
patients. (2) a detailed part with data collection of patients recently diagnosed
for HF-PSF (LVEF ≥ 45% evaluated within 8 days following hospitalization
date).
Results: 707 HF patients were enrolled in the registry with a proportion of
51% with HF-PSF. In detailed part 364 HF-PSF patients were selected, with a
mean age of 79 years, 59%female, and a mean BMI 27.7kg/m.
Main cardiovascular characteristics of HF-PSF patients were: atrial fibrilla-
tion (51%), coronary heart disease (32%), peripheral arterial disease (15%)
and stroke (13%) as CV antecedents and hypertension (78%), obesity (45.5%)
and diabetes (29%) as risk factors.
Mean values were: blood pressure 133/86mmHg, HR 92beats/min, creati-
nine 13.8mg/l, haemoglobin 12.0g/dl. BNP was performed in 243 patients with
a median value of 684 pg/ml and Nt-pro-BNP in 77 patients with a median
value of 3999 pg/ml. Mean ejection fraction was 58±8%.
Non CV co-morbidities were: renal failure(39%), COPD(20%), walking
disorders (22%), depression(12%),cognitive disorders(8%)and cancers(5%).
Treatment at discharge included: diur. (85%), ACE-i(57%), βB (56%), Ca
antag (27%), ARB (20%), aldosterone blockers (13%), digoxin (16%), antico-
agulants (52%), statins (48%), aspirin (32%) and amiodarone (28.5%).
Conclusion: Much is not known about the epidemiology and management
of HF-FSP in France but our study try to improve the knowledge on this dis-
ease with real life data even if until today there is no specific treatment.
116
Cardiac remodeling and failure late after myocardial infarction is
exacerbated by tissue hypothyroidism
Iordanis Mourouzis (1), Nikolaos Tsagoulis (1), Georgios Galanopoulos (1),
Maria Gavra (1), Philippos Perimenis (1), Danai Spanou (1), Constantinos
Pantos (1), Dennis Cokkinos (2)
(1) University of Athens, Medical School, Pharmacology, Athens, Grèce –
(2) Onassis Cardiac Surgery Center and Biomedical Research Founda-
tion-Academy, Athens, Grèce
Previous studies have shown that thyroid hormone (TH) signaling is altered
after acute myocardial infarction or myocardial hypertrophy with potential
physiological consequences. We investigated whether such changes are related
to the severity of cardiac dysfunction.
Myocardial infarction was induced in rats by coronary artery ligation
(AMI), while SHAM operated animals served as controls (SHAM, n=8). Both
AMI and SHAM hearts were studied after 34 weeks. AMI were divided to
heart failure (AMI-HF, n=6) and non-heart failure group (AMI-NHF, n=7) as
assessed by the ratio of lung weight to body weight (LGW/BW) and right ven-
tricle weight to body weight (RV/BW). Contractile function and left ventric-
ular (LV) remodeling was assessed by echocardiography. TRα1 was increased
in both border and remote regions of viable LV of AMI-NHF (2.0 fold and 1.8
fold), while it decreased in AMI-HF (2.0 fold and 1.5 fold) vs SHAM, p<0.05.
TRβ1 was reduced in border and remote regions in AMI-HF (2.8 fold and 2.0
fold) and AMI-NHF (3.6 fold and 2.0 fold) vs SHAM, p<0.05. T3 and T4
were not different between groups. Accordingly, this response corresponded to
changes in cardiac function (table) and in MHC isoform expression. A marked
increase in β-MHC was observed in both border and remote regions of LV of
AMI-HF (76% and 75%), p<0.05 vs both SHAM and AMI-NHF while a small
but significant increase in β-MHC was found in both border and remote
regions of LV in AMI-NHF (62% and 60%) as compared to SHAM (48% and
50%).
 LGW/BW RV/BW LVEDD (mm)
LVEDS 
(mm) EF%
SHAM 3.77 (0.15) 0.35 (0.02) 6.9 (0.15) 4.0 (0.2) 75.6 (2.3)
AMI-HF 3.95 (0.4) 0.43 (0.02) 8.8 (0.22)* 7.1 (0.3)* 41.2 (2.6)
AMI-NHF 6.90 (0.8)** 0.82 (0.1)** 10.4 (0.50)** 9.2 (0.5)** 27 (2.0)
*p<0.05 vs SHAM, **p<0.05 vs SHAM and AMI-HF 
Post-infarct remodelling results in tissue hypothyroidism. The occurrence of heart 
failure is accompanied by distinct changes in TR and MHC isoform expression 
corresponding to a marked regression to the fetal pattern.
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